日冕(行星地质学)
纳米颗粒
载脂蛋白B
作文(语言)
体内
脂蛋白
化学
高密度脂蛋白
体外
功能(生物学)
计算生物学
胆固醇
纳米技术
生物
细胞生物学
材料科学
生物化学
遗传学
语言学
哲学
天体生物学
维纳斯
作者
Kai Liu,Ralf Nilsson,Elisa Lázaro‐Ibáñez,Hanna Duàn,Tasso Miliotis,Marie Strimfors,Michael Lerche,Ana Rita Salgado Ribeiro,Johan Ulander,Daniel Lindén,Anna Salvati,Alan Sabirsh
标识
DOI:10.1038/s41467-023-39768-9
摘要
Abstract In terms of lipid nanoparticle (LNP) engineering, the relationship between particle composition, delivery efficacy, and the composition of the biocoronas that form around LNPs, is poorly understood. To explore this we analyze naturally efficacious biocorona compositions using an unbiased screening workflow. First, LNPs are complexed with plasma samples, from individual lean or obese male rats, and then functionally evaluated in vitro. Then, a fast, automated, and miniaturized method retrieves the LNPs with intact biocoronas, and multiomics analysis of the LNP-corona complexes reveals the particle corona content arising from each individual plasma sample. We find that the most efficacious LNP-corona complexes were enriched with high-density lipoprotein (HDL) and, compared to the commonly used corona-biomarker Apolipoprotein E, corona HDL content was a superior predictor of in-vivo activity. Using technically challenging and clinically relevant lipid nanoparticles, these methods reveal a previously unreported role for HDL as a source of ApoE and, form a framework for improving LNP therapeutic efficacy by controlling corona composition.
科研通智能强力驱动
Strongly Powered by AbleSci AI